DT-diaphorase protects cells from the hypoxic cytotoxicity of indoloquinone EO9

This publication has 27 references indexed in Scilit:

• Chemosensitivity to the indoloquinone EO9 is correlated with DT-diaphorase activity and its gene expression
  Biochemical Pharmacology, 1994
• Unusually marked hypoxic sensitization to indoloquinone E09 and mitomycin C in a human colon‐tumour cell line that lacks DT‐diaphorase activity
  International Journal of Cancer, 1994
• EO9: A novel bioreductive alkylating indoloquinone with preferential solid tumour activity and lack of bone marrow toxicity in preclinical models
  European Journal Of Cancer, 1993
• Bioactivation of Mitomycin C by Xanthine Dehydrogenase From EMT6 Mouse Mammary Carcinoma Tumors
  JNCI Journal of the National Cancer Institute, 1992
• The sensitivity of human tumour cells to quinone bioreductive drugs: What role for DT-diaphorase?
  Biochemical Pharmacology, 1992
• DT-diaphorase and cancer chemotherapy
  Biochemical Pharmacology, 1992
• Enzymology of the reductive bioactivation of SR 4233
  Biochemical Pharmacology, 1990
• The differential hypoxic cytotoxicity of bioreductive agents determined in vitro by the MTT assay
  International Journal of Radiation Oncology*Biology*Physics, 1989
• Generation of hydroxyl radical by anticancer quinone drugs, carbazilquinone, mitomycin C, aclacinomycin A and adriamycin, in the presence of NADPH-cytochrome P-450 reductase
  Biochemical Pharmacology, 1982
• One-electron-transfer reactions in biochemical systems V. Difference in the mechanism of quinone reduction by the NADH dehydrogenase and the NAD(P)H dehydrogenase (DT-diaphorase)
  Biochimica et Biophysica Acta (BBA) - Bioenergetics, 1970